R.L.Fine Chem is an API manufacturer based in India. It holds 14 active US drug master files across a filed portfolio of 13 molecules. Its GMP standing is certified by CDSCO (India). Its most recent recorded inspection, by US FDA, closed on 14 April 2023 as VAI. Customs aggregates show $10.7M of exports covering 423 molecules to 64 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Bangalore, India | 3005560263 |
| chickkaballapur, India | Not on file |
| bengaluru 560 064, India | Not on file |
| Bengaluru, India | Not on file |
| Hindupur, India | 3039941881 |
| Bengaluru, India | 3013140488 |
| Molecule | Regulators | Docs |
|---|---|---|
| Orphenadrine | US FDA | 2 |
| Buspirone | US FDA | 1 |
| Carbinoxamine | US FDA | 1 |
| Chlordiazepoxide | US FDA | 1 |
| Clonazepam | US FDA | 1 |
| Clozapine | US FDA | 1 |
| Diazepam | US FDA | 1 |
| Doxepin | US FDA | 1 |
| Eszopiclone | US FDA | 1 |
| Meclizine | US FDA | 1 |
| Pramocaine | US FDA | 1 |
| Sertraline | US FDA | 1 |
| Temazepam | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 2 | None |
| CDSCO (India) | None | 4 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $8.3M | 41 |
| 2025 | Not reported | $10.7M | 64 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. R.L.Fine Chem comes back tiered against every other supplier able to file there.
Start for free